So for example, companies including Roche AG, Pfizer Inc. and GlaxoSmithKline plc are now systematically forming one-to-one relationships with academic groups.it is also the case that academic and charitable bodies are pooling resources in an attempt to help new science over the gulf that exists between the outputs of research funded by public grants and programs that can attract private capital to